Literature DB >> 18174780

What factors contribute to the inadequate control of elevated blood pressure?

William J Elliott1.   

Abstract

Inadequate control of blood pressure may be attributed to both provider-related and patient-related factors. Health care provider-related factors may include an excessive reliance on monotherapy and reluctance to increase drug doses or add additional antihypertensive agents to the treatment regimen. The primary patient-related factor is nonadherence with the prescribed antihypertensive medication. Although the high cost of therapy is sometimes a reason for poor adherence, drug side effects or dosing considerations may be more important factors. Better adherence with antihypertensive medication is associated with a significantly greater likelihood of achieving blood pressure control and, consequently, with lower costs and reduced utilization of health care resources. Therefore, strategies that improve long-term adherence should be adopted. Single-pill, or fixed-dose, combination therapy is one approach that improves adherence, while also providing the antihypertensive efficacy needed to help patients achieve their blood pressure goals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174780      PMCID: PMC8110129          DOI: 10.1111/j.1524-6175.2007.08028.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  49 in total

Review 1.  Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?

Authors:  K A Payne; S Esmonde-White
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

2.  Fixed-dose combinations improve medication compliance: a meta-analysis.

Authors:  Sripal Bangalore; Gayathri Kamalakkannan; Sanobar Parkar; Franz H Messerli
Journal:  Am J Med       Date:  2007-08       Impact factor: 4.965

3.  Challenges for improving medication adherence.

Authors:  Ross J Simpson
Journal:  JAMA       Date:  2006-11-13       Impact factor: 56.272

4.  Impact of poorly controlled hypertension on healthcare resource utilization and cost.

Authors:  L C Paramore; M T Halpern; P Lapuerta; J S Hurley; F J Frost; D G Fairchild; D Bates
Journal:  Am J Manag Care       Date:  2001-04       Impact factor: 2.229

5.  Clinical practice and recent recommendations in hypertension management--reporting a gap in a global survey of 1259 primary care physicians in 17 countries.

Authors:  Peter Bramlage; Martin Thoenes; Wilhelm Kirch; Claude Lenfant
Journal:  Curr Med Res Opin       Date:  2007-04       Impact factor: 2.580

6.  Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice.

Authors:  M Di Martino; L Degli Esposti; F Filigheddu; C Veronesi; G Salerno; S Saragoni; N Glorioso; G Didoni; E Degli Esposti
Journal:  J Hum Hypertens       Date:  2006-10-12       Impact factor: 3.012

7.  Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

Authors:  Kwok Leung Ong; Bernard M Y Cheung; Yu Bun Man; Chu Pak Lau; Karen S L Lam
Journal:  Hypertension       Date:  2006-12-11       Impact factor: 10.190

8.  Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care.

Authors:  Deborah A Taira; Ken S Wong; Feride Frech-Tamas; Richard S Chung
Journal:  Am J Manag Care       Date:  2006-11       Impact factor: 2.229

9.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry A J Struijker Boudier; Alberto Zanchetti; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Gerasimos Filippatos; Christian Funck-Brentano; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; Jose Luis Zamorano; Sverre E Kjeldsen; Serap Erdine; Krzysztof Narkiewicz; Wolfgang Kiowski; Enrico Agabiti-Rosei; Ettore Ambrosioni; Renata Cifkova; Anna Dominiczak; Robert Fagard; Anthony M Heagerty; Stephane Laurent; Lars H Lindholm; Giuseppe Mancia; Athanasios Manolis; Peter M Nilsson; Josep Redon; Roland E Schmieder; Harry A J Struijker-Boudier; Margus Viigimaa; Gerasimos Filippatos; Stamatis Adamopoulos; Enrico Agabiti-Rosei; Ettore Ambrosioni; Vicente Bertomeu; Denis Clement; Serap Erdine; Csaba Farsang; Dan Gaita; Wolfgang Kiowski; Gregory Lip; Jean-Michel Mallion; Athanasios J Manolis; Peter M Nilsson; Eoin O'Brien; Piotr Ponikowski; Josep Redon; Frank Ruschitzka; Juan Tamargo; Pieter van Zwieten; Margus Viigimaa; Bernard Waeber; Bryan Williams; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2007-06-11       Impact factor: 29.983

10.  Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension.

Authors:  Cathy B Spranger; Andrea J Ries; Carrie A Berge; Nina B Radford; Ronald G Victor
Journal:  Am J Med       Date:  2004-07-01       Impact factor: 4.965

View more
  34 in total

1.  Blood Pressure Management in Intracranial Hemorrhage: Current Challenges and Opportunities.

Authors:  Cheryl Carcel; Shoichiro Sato; Craig S Anderson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-04

Review 2.  Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidence.

Authors:  Massimo Volpe; Giuliano Tocci
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

3.  Medication adherence: WHO cares?

Authors:  Marie T Brown; Jennifer K Bussell
Journal:  Mayo Clin Proc       Date:  2011-03-09       Impact factor: 7.616

4.  Optimizing blood pressure control in patients with chronic kidney disease.

Authors:  Biff F Palmer; Andrew Z Fenves
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-07

5.  Prevalence of Apparent Treatment-Resistant Hypertension in the United States.

Authors:  Robert M Carey; Swati Sakhuja; David A Calhoun; Paul K Whelton; Paul Muntner
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

6.  Improved blood pressure control in elderly hypertensive patients: results of the PAPY-65 Survey.

Authors:  Patricia Van der Niepen; Alain G Dupont
Journal:  Drugs Aging       Date:  2010-07-01       Impact factor: 3.923

Review 7.  Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects.

Authors:  J Ø Nielsen; A D Shrestha; D Neupane; P Kallestrup
Journal:  J Hum Hypertens       Date:  2016-06-16       Impact factor: 3.012

8.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

9.  Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update.

Authors:  Maurizio Destro; Francesca Cagnoni; Antonio D'Ospina; Alessandra Rossi Ricci; Elena Demichele; Emmanouil Peros; Augusto Zaninelli; Paola Preti
Journal:  Vasc Health Risk Manag       Date:  2010-04-15

10.  Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.

Authors:  Dion Zappe; Cheraz Cherif Papst; Philippe Ferber
Journal:  Vasc Health Risk Manag       Date:  2009-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.